UK reviewing Palantir's NHS contract amid pressure to use break clause - Finance news and analysis from Global Banking & Finance Review
Finance

UK reviewing Palantir's NHS contract amid pressure to use break clause

Published by Global Banking & Finance Review

Posted on June 9, 2026

3 min read

· Last updated: June 9, 2026

Add as preferred source on Google

UK Government Reviews Palantir’s NHS Data Platform Contract Amid Criticism

Review and Criticism of Palantir’s NHS Data Platform Contract

Government Review of the Palantir Contract

LONDON, June 9 (Reuters) - Britain is conducting a full review of its National Health Service contract with U.S. data analytics firm Palantir, amid growing political pressure for the government to use a break clause at the end of the initial term in early 2027.

Technology minister Liz Kendall said on Tuesday the review would assess whether to extend the £330 million ($441 million) deal under provisions allowing the government to continue it for up to seven years or terminate it.

Ministerial Statement on the Contract

"The current health secretary is reviewing every single aspect of that (contract) to make sure we get the right deal for Britain," Kendall told Times Radio, referring to concerns about patient confidentiality, public trust and reliance on a U.S. supplier.

The contract, awarded in 2023 to build a platform linking NHS data, runs until early 2027, when the government must decide whether to extend it.

Parliamentary and Public Criticism

Parliamentary Committee Concerns

PARLIAMENTARY CRITICISM

A parliamentary committee last week urged ministers to trigger the clause and end the contract, warning Palantir's role represents an "unacceptable point of weakness" and highlighting risks from relying on a small number of U.S. tech firms.

The committee said the company's growing role in the public sector raised concerns about dependence on overseas suppliers and the resilience of critical services, while noting officials reported benefits in areas such as waiting list management, operations and hospital discharge planning.

Controversies Surrounding Palantir

The deal has also drawn scrutiny because Palantir supplies software to the U.S. military and immigration authorities, and over the political views of its billionaire co-founder Peter Thiel, an early supporter of President Donald Trump.

Concerns About Data Handling and Access

Campaigners and unions have raised concerns about the handling of sensitive health data. Last month, the Financial Times reported NHS officials had proposed granting some external staff, including Palantir personnel, broad administrative access to identifiable patient data on parts of the system. 

Palantir has said its software helps improve patient care and efficiency across the NHS.

Neither Palantir nor NHS England immediately responded to requests for comment.

Related Developments in Public Procurement

Separately, London Mayor Sadiq Khan last month blocked a £50 million police contract with Palantir, citing concerns about value for money and whether companies' ethics should be considered in public procurement.  

($1 = 0.7486 pounds)

(Reporting by Sam Tabahriti. Editing by Mark Potter)

Key Takeaways

  • The NHS deal, awarded in late 2023 for the Federated Data Platform (FDP) worth up to £330 million over seven years, is being fully reassessed by ministers amid scrutiny over privacy and vendor dependence (ukfactcheck.com).
  • A parliamentary committee labelled reliance on Palantir an “unacceptable point of weakness” and urged exercising the break clause in 2027 to reduce reliance on US tech providers (aa.com.tr).
  • Critics—from MPs, campaigners, NHS staff and unions—have raised alarms over patient confidentiality, transparency, ethics and value for money; Palantir maintains it acts solely as a data processor under NHS control (techradar.com).

References

Frequently Asked Questions

Why is the UK reviewing its NHS contract with Palantir?
The UK is reviewing the Palantir NHS contract due to political pressure and concerns around patient confidentiality, public trust, and reliance on a US supplier.
What is the break clause in the Palantir NHS contract?
The break clause allows the UK government to terminate the contract at the end of the initial term in early 2027 instead of extending it.
What are the main concerns about Palantir’s involvement with the NHS?
Concerns include the handling of sensitive health data, growing dependence on a US tech firm, and risks to critical public services.
Has Palantir responded to the review of its NHS contract?
As of now, neither Palantir nor NHS England have responded to requests for comment regarding the ongoing review.
What were the reported benefits of Palantir’s NHS platform?
Officials noted benefits in managing waiting lists, operations, and hospital discharge planning through Palantir's platform.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category